CME GROUP INC.

Listed Company

CMECIK 0001156375NasdaqLarge AcceleratedSecurity & Commodity Brokers, Dealers, Exchanges & ServicesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$6.52B

Net Income

$4.07B

Total Assets

$198.42B

Equity

$28.73B

Shares Out

66.64M

Op. Cash Flow

$4.28B

Business

CME Group Inc. operates global financial markets infrastructure that enables clients to trade futures, options, cash and OTC products, clear trades, and access market data and analytics. It offers listed derivatives, cash and repo fixed income trading (BrokerTec), spot and OTC FX trading (EBS), central counterparty clearing, proprietary market data, indices and research and analytics tools. Key business segments comprise its Derivatives Exchange business, CME Clearing, Cash Markets (BrokerTec and EBS) and Market Data services. Its products and services are distributed globally via electronic platforms (primarily CME Globex), open outcry for select contracts, proprietary front-end applications, cloud partnerships and third-party distribution partners.

Summary from filing dated 2025-02-27

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total Revenues	6,521	6,130	5,579	5,019	4,690
Compensation and benefits	907	850	829	753	837
Technology	283	256	219	189	193
Professional fees and outside services	151	133	144	137	152
Amortization of purchased intangibles	223	222	227	228	238
Depreciation and amortization	108	115	126	135	148
Licensing and other fee agreements	371	355	323	320	237
Other	249	268	276	242	241
Total Expenses	2,291	2,199	2,143	2,004	2,045
Operating Income	4,230	3,932	3,436	3,016	2,645
Investment income	5,737	4,079	5,275	2,198	307
Interest and other borrowing costs	−173	−161	−159	−163	−167
Equity in net earnings (losses) of unconsolidated subsidiaries	372	351	297	301	246
Other income (expense)	−4,834	−3,659	−4,695	−1,862	343
Total Non-Operating	1,101	610	718	474	728
Income before Income Taxes	5,331	4,541	4,154	3,490	3,374
Income tax provision	1,258	1,016	927	799	737
Net income	4,072	3,526	3,226	2,691	2,637
Net income attributable to CME Group	4,072	3,526	3,226	2,691	2,637
Net Income Attributable to Common Shareholders of CME Group	4,021	3,482	3,186	2,657	2,617
Basic (per share)	11.18	9.69	8.87	7.41	7.3
Diluted (per share)	11.16	9.67	8.86	7.4	7.29
Basic (shares)	360	359	359	359	358
Diluted (shares)	360	360	360	359	359

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	4,417	2,892	2,912	2,720	2,835
Marketable securities	125	113	112	96	115
Accounts receivable, net of allowance	639	573	536	483	435
Other current assets	522	559	1,138	530	428
Performance bonds and guaranty fund contributions	159,656	98,895	90,193	135,249	157,950
Total current assets	165,359	103,034	94,890	139,078	161,762
Property, net of accumulated depreciation and amortization	363	386	410	456	505
Intangible assets-trading products	17,175	17,175	17,175	17,175	17,175
Intangible assetsother, net	2,611	2,822	3,050	3,270	3,532
Goodwill	10,515	10,487	10,495	10,483	10,528
Other assets	2,402	3,544	3,686	3,714	3,278
Total Assets	198,424	137,447	129,706	174,176	196,780
Accounts payable	72	80	91	121	49
Short-term debt	0	750	0	16	749
Other current liabilities	569	2,589	3,134	2,301	1,651
Performance bonds and guaranty fund contributions	159,656	98,895	90,193	135,249	157,950
Total current liabilities	160,297	102,314	93,417	137,688	160,398
Long-term debt	3,422	2,678	3,425	3,422	2,696
Deferred Income Tax Liabilities, Net	5,242	5,247	5,328	5,361	5,390
Other liabilities	735	721	798	826	897
Total Liabilities	169,696	110,960	102,968	147,297	169,381
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued or outstanding	0	0	0	0	0
Additional paid-in capital	22,210	22,403	22,335	22,262	22,190
Retained earnings	6,433	4,186	4,455	4,747	5,152
Accumulated other comprehensive income (loss)	82	−106	−56	−133	54
Total CME Group Shareholders' Equity	28,728	26,487	26,738	26,879	27,399
Total Liabilities and Shareholders' Equity	198,424	137,447	129,706	174,176	196,780

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Stock-based compensation	95	90	83	84	75
Net realized and unrealized gains on investments	−353	−4	−72	−5	−117
Deferred income taxes	−6	−66	−75	−23	35
Accounts receivable	−67	−39	−52	−51	−46
Other current assets	−18	665	−638	−77	−55
Other assets	50	75	92	87	61
Accounts payable	−8	−11	−31	73	−19
Income tax payable	91	−117	−77	−148	−121
Other current liabilities	87	−706	643	88	62
Other liabilities	−35	−55	−33	−67	−45
Other	38	−3	34	41	−20
Net Cash Provided by Operating Activities	4,277	3,691	3,454	3,056	2,402
Proceeds from maturities and sales of available-for-sale marketable securities	8	6	6	6	9
Purchases of available-for-sale marketable securities	6	5	4	4	8
Purchases of property, net	−84	−94	−76	−90	−127
Investments in business ventures	11	4	2	3	5
Proceeds from sale of business ventures	1,591	14	98	11	101
Net Cash Used in Investing Activities	1,499	−83	21	−490	58
Proceeds from debt, net of issuance costs	741	0	0	741	0
Repayment of other borrowings, including call premiums	−750	0	−16	−756	0
Cash dividends	−3,933	−3,584	−3,236	−2,634	−2,189
Payments for (Proceeds from) Derivative Instrument, Financing Activities	−266	0	0	—	0
Change in performance bond and guaranty fund contributions	60,761	8,703	−45,057	−22,700	71,168
Employee taxes paid on restricted stock vesting	−34	−33	−21	−25	−32
Other	−9	−9	−9	−8	−3
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	56,510	5,077	−48,339	−25,382	69,909
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	62,285	8,684	−44,865	−22,816	72,370
Income taxes paid	1,164	1,197	1,072	973	755
Interest paid	136	130	130	133	133
Dividends declared	0	2,112	1,910	1,636	1,184

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro